CN110105349A - The synthetic method and its application of topramezone impurity - Google Patents

The synthetic method and its application of topramezone impurity Download PDF

Info

Publication number
CN110105349A
CN110105349A CN201910355436.5A CN201910355436A CN110105349A CN 110105349 A CN110105349 A CN 110105349A CN 201910355436 A CN201910355436 A CN 201910355436A CN 110105349 A CN110105349 A CN 110105349A
Authority
CN
China
Prior art keywords
methyl
phenyl
dihydro
isoxazole
topramezone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910355436.5A
Other languages
Chinese (zh)
Inventor
张越
吴晓东
武志颖
郭庆春
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEBEI LANSHENG BIOTECH Co.,Ltd.
Original Assignee
Hebei University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hebei University of Science and Technology filed Critical Hebei University of Science and Technology
Priority to CN201910355436.5A priority Critical patent/CN110105349A/en
Publication of CN110105349A publication Critical patent/CN110105349A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography

Abstract

The invention discloses a kind of synthetic methods of topramezone impurity; with 2; 3- dimethylaniline is starting material; by first vulcanization, bromo, oxidation, at oxime, chloro cyclization synthesis 3- [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4; 5- dihydro-isoxazole; it is condensed under alkaline condition with 1- methyl -5- hydroxypyrazoles, and synthesis 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- dihydro-isoxazole;The invention also discloses a kind of applications of corresponding product.Synthetic method provided by the present invention is easy to operate, and process is easily controllable, and the yield of products obtained therefrom is 40%~80%, and obtained product can be used as standard items, for detecting and monitoring the synthesis of topramezone.

Description

The synthetic method and its application of topramezone impurity
Technical field
The invention belongs to pharmaceutical fields, are related to a kind of synthetic method of pesticide topramezone impurity, i.e. 3- [2- methyl -3- (1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- dihydro-isoxazole synthetic method and corresponding close At the application of product.
Background technique
In the production process of drug, it is frequently accompanied by the generation of impurity, not only will affect product yield, but also will affect medicine The quality of product, and then influence the use of drug.Effective monitoring is carried out for guaranteeing product matter to the impurity during synthesis The influence of amount, yield and reduction impurity to drug effectiveness plays a key role.
Topramezone (Topramezone), chemical name are as follows: [3-(4,5- dihydro -3- isoxazolyl) -2- methyl -4-(first Base sulfonyl) phenyl]-(5- hydroxyl -1- methyl-1 H- pyrazoles -4- base) ketone, sterling is white powder solid, molecular formula: C16H17N3O5S, molecular weight: 363.39.Structural formula is as follows:
Topramezone is the novel 4- medical midbodies of para (ortho)-hydroxybenzoic acetone acid esters dual oxide enzyme of the newest research and development listing of BASF Aktiengesellschaft (HPPD) inhibitor corn field herbicide after seedling.It can hinder synthesis and the photosynthesis of chloroplaset of carotenoid, finally Cause the weeds albefaction containing HPPD enzyme dead.Most of corn is had good selectivity, including ordinary maize, Sweety and waxy corn, it is best to the safety of corn at present.
And topramezone can be synthesized using following synthetic route in industrial production at present:
The synthetic route of topramezone
During being synthesized with said synthesis route, the 1- methyl -5- hydroxypyrazoles in polar aprotic solvent are found Easily occur on phenyl ring under alkaline condition with 3- [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole Substitution reaction, to generate 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4, 5- dihydro-isoxazole.Above-mentioned generation 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) benzene Base] -4,5- dihydro-isoxazole directly affects the synthesis yield of topramezone, and there is no about this miscellaneous in document before The relevant report of matter, therefore it is not provided with controlling measurement reaction condition in the prior art, it avoids generating 3- [2- methyl -3-(1- Methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- dihydro-isoxazole.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of topramezone impurity, i.e. 3- [2- methyl -3-(1- methyl - 1H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] and -4,5- dihydro-isoxazole synthetic method, with 3- [the bromo- 2- first of 3- Base -6-(methyl sulphonyl) phenyl] -4,5- dihydro-isoxazole is condensed with 1- methyl -5- hydroxypyrazoles under alkaline condition, Synthesis 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- dihydro-isoxazole.It should Synthetic method process is simple, easily controllable, and yield is 40~80%.
Another object of the present invention is to provide 3- obtained above [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygen Base) -6-(methyl sulphonyl) phenyl] and -4,5- dihydro-isoxazole a kind of application.It as standard items, can be used for detecting and Monitor the synthesis of topramezone.
In order to solve the above technical problems, the technical scheme adopted by the invention is that:
A kind of synthetic method of topramezone impurity, the impurity be 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) - 6-(methyl sulphonyl) phenyl] -4,5- dihydro-isoxazole, synthetic method includes the following steps successively carried out:
1) prepared by raw material, including preparation 3- [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole and 1- Methyl -5- hydroxypyrazoles, the system of [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole wherein the 3- Preparation Method is, with 2,3- dimethylaniline for starting material, by first vulcanization, bromo, oxidation, at oxime, chloro cyclization synthesis 3- [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole;
The synthetic method of the 1- methyl -5- hydroxypyrazoles is to synthesize 1- first with methyl hydrazine reaction with 3- methoxy-methyl acrylate Base -5- hydroxypyrazoles;
2) condensation reaction
By the 3- of preparation [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole and 1- methyl -5- hydroxyl Condensation reaction occurs under alkaline condition for pyrazoles, be finally prepared 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) - 6-(methyl sulphonyl) phenyl] -4,5- dihydro-isoxazole.
The synthetic line of 3- in above-mentioned reaction [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole Are as follows:
The synthetic route of 1- methyl -5- hydroxypyrazoles is as follows:
And then synthetic route of the invention are as follows:
As the restriction to step 2 in the present invention: the step 2 sequentially carries out in accordance with the following steps:
1. catalyst alkali and 3- [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole is added to solvent A Middle dissolution obtains solution B, and by solution B, is warming up to 80~150 DEG C;
2. being added dropwise in reaction flask after 1- methyl -5- hydroxypyrazoles are dissolved with solvent A, mixed with solution B, and 1. in step At a temperature of fully reacting, after the reaction was completed reaction liquid C;
3. reaction liquid C is down to room temperature and is poured onto ice water, is extracted, be washed with water organic with ethyl acetate or methylene chloride Phase is concentrated later up to 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- bis- Hydrogen isoxazole.
As the limiting 1. to step in the present invention: the step 1. in catalyst alkali as sodium carbonate, potassium carbonate, hydrogen-oxygen Change any one in sodium or potassium hydroxide, the dosage and 3- of the alkali [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] - The molar equivalent ratio of 4,5- dihydro-isoxazole dosage is 0.5~5:1.
Limited as to solvent A in the present invention: the step 1. with step 2. used in solvent A as DMF, DMAC, Any one in NMP.
It is limited as to another kind of the invention: the 1- methyl -5- hydroxypyrazoles and 3- [the bromo- 2- methyl -6-(first of 3- Base sulfonyl) phenyl] -4,5- dihydro-isoxazole dosage molar equivalent ratio be 1~1.5:1.
The present invention also provides a kind of 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) Phenyl] -4,5- dihydro-isoxazole application, the 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphur Acyl group) phenyl] -4,5- dihydro-isoxazole is as standard items, to detect and monitor the synthesis of topramezone.
Compared with prior art, the present invention acquired progress is: the present invention provides in topramezone production process The impurity of generation: 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- dihydro is different The reaction process and reaction condition of oxazole can be known according to above-mentioned reaction and generate 3-
Needed for [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- dihydro-isoxazole Condition, and then can be during generating topramezone according to the present invention to 3- [2- methyl -3-(1- methyl-1 H- pyrazoles - 5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- dihydro-isoxazole is monitored, and then realizes detection and monitoring topramezone The purpose of synthesis generates beneficial effect to the income of topramezone.
The present invention is described in further detail below in conjunction with specific embodiment.
Detailed description of the invention
Fig. 1 be 1-7 of the embodiment of the present invention in synthesize 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(first Base sulfonyl) phenyl] -4,5- dihydro-isoxazole LCMS figure;
Fig. 2 be inventive embodiments 1-7 in synthesize 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(sulfonyloxy methyl Base) phenyl] -4,5- dihydro-isoxazole1HNMR figure;
Fig. 3 is 1- methyl -5- hydroxypyrazoles in 1-7 of the embodiment of the present invention1HNMR figure;
Fig. 4 is 3- [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole in 1-7 of the embodiment of the present invention1HNMR figure;
Fig. 5 is 2,3- dimethyl benzene thiomethane in 1-7 of the embodiment of the present invention1HNMR figure
Fig. 6 is 2,3- dimethyl -4- methyl sulphonyl bromobenzene in 1-7 of the embodiment of the present invention1HNMR figure;
Fig. 7 is the bromo- 2- methyl -6- methyl sulphonyl benzaldoxime of 3- in 1-7 of the embodiment of the present invention1HNMR figure;
Fig. 8 a is that 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- dihydro is different Oxazole liquid phase figure;
Fig. 8 b is topramezone standard items liquid phase figure;
Fig. 8 c is the liquid phase figure of topramezone in production.
Specific embodiment
Embodiment 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- two The synthetic method of hydrogen isoxazole
The present embodiment includes the following steps successively carried out:
1) prepared by raw material, including preparation 3- [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole and 1- Methyl -5- hydroxypyrazoles, the system of [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole wherein the 3- Preparation Method are as follows: with 2,3- dimethylaniline be starting material, by first vulcanization, bromo, oxidation, at oxime, chloro cyclization synthesis 3- [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole, specific synthetic route are shown in route 1.
Route 1
The synthesis of 2,3- dimethyl benzene thiomethane, the conjunction of 2,3- dimethyl -4- methyl thio bromobenzene are contained in the route 1 At, the synthesis of 2,3- dimethyl -4- methyl sulphonyl bromobenzene, the synthesis of the bromo- 2- methyl -6- methyl sulphonyl benzaldoxime of 3-, The synthesis of 3- [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole, the present embodiment will be to above-mentioned five kinds The synthesis of substance is illustrated respectively.
A dimethyl disulfide 500g, 2,3-) the synthesis of 2,3- dimethyl benzene thiomethane: are added in 1000 mL flasks Dimethylaniline 100g, copper powder 52.55g are warming up to 50 DEG C, and in nitrite tert-butyl 135g is added dropwise in 3 hours, lye absorbs Tail gas.Drop finishes, and continuation is reacted one hour at 50 DEG C.After the reaction was completed, copper powder is filtered, sodium bicarbonate solution washs filtrate, subtracts Pressure distillation separation dimethyl disulfide and product 2,3- dimethyl benzene thiomethane.The synthetic1HNMR schemes such as Fig. 5 institute Show.
B) the synthesis of 2,3- dimethyl -4- methyl thio bromobenzene: at room temperature, 2,3- are added in 1000 mL four-hole bottles Dimethyl benzene thiomethane 109g, 400 mL of acetic acid.N2The lower mixed liquor that 114g bromine and 100 mL acetic acid is added dropwise of protection, alkali Liquid absorbs exhaust gas, and the reaction was continued 1 hour after drop finishes.Filter solid is crossed after the reaction was completed, and filtrate is added sodium acetate stirring, steams vinegar Methylene chloride, water stirring is added in acid, and concentration dichloro is mutually up to 2,3- dimethyl -4- methyl thio bromobenzene.
C) the synthesis of 2,3- dimethyl -4- methyl sulphonyl bromobenzene: at 100 DEG C, to 182g 2,3- dimethyl -4- first 266 g (30%) aqueous hydrogen peroxide solution is added dropwise in 600 mL acetums of the thio bromobenzene of base and 5.24g tungstic acid hydrate sodium, It is added dropwise, continues to react 1 hour at this temperature.Reaction solution is cooled to 70 DEG C, and elutriation is added into reaction solution and produces Object, filtering, 2,3- dimethyl -4- methyl sulphonyl bromobenzene obtained by drying.The synthetic1HNMR figure is as shown in Figure 6.
D) the synthesis of the bromo- 2- methyl -6- methyl sulphonyl benzaldoxime of 3-: 276 g sodium methoxides are dissolved in 0.4 L's In DMF, and 400g 2,3- dimethyl -4- methyl sulphonyl bromobenzene and 216.4g nitrous are added thereto in -20 DEG C~-15 DEG C The 0.8L DMF solution of acid butyl ester then adds 100g sodium methoxide, the total stirring of reaction mixture 5.5 hours again.
Mixture is poured in 4L ice water and 0.4L acetic acid, and with the tertiary ether extraction of 4L first in total, is washed with sodium bicarbonate solution Organic phase is washed, organic phase is concentrated, obtains the bromo- 2- methyl -6- methyl sulphonyl benzaldoxime of 3-.The synthetic1HNMR figure As shown in Figure 7.
E) the synthesis of 3- [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole: at 60 DEG C, A small amount of N- chloro succinyl is added into 200 mL DMF solutions of the bromo- 2- methyl -6- methyl sulphonyl benzaldoxime of 50g 3- Imines.Reaction measures the N- chlorosuccinimide of total amount of adding 23.3g in 40 DEG C~50 DEG C once rear.Reaction solution is again Stirring 30 minutes, until fully reacting, reaction mixture is poured in ice water, crosses filter solid, and wash twice.Solid is directly used In the next step.
Solid is dissolved in 250mL methylene chloride, ethylene gas displacement, it is not open close enter ethylene gas, be added dropwise simultaneously 20.3g triethylamine reacts at room temperature 72 hours in the case where being constantly passed through ethylene.After the reaction was completed, it washes, and solvent is evaporated off to get 3- [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole.The synthetic1HNMR schemes such as Fig. 4 institute Show.
And the synthetic method of the 1- methyl -5- hydroxypyrazoles in the present embodiment is: under ice-water bath, burning to tetra- mouthfuls of 1000mL Methanol 170g is added in bottle.116g 3- methoxy-methyl acrylate, 262.8g (35%) methyl hydrazine water is added dropwise into flask simultaneously Solution.It is added dropwise, the reaction was continued 2 hours.After the reaction was completed, decompression steams methanol, water and methyl hydrazine.Up to product 1- first Base -5- hydroxypyrazoles.Specific synthetic route is shown in route 2.The synthetic1HNMR figure is as shown in Figure 3.
Route 2
2) condensation reaction
By the 3- of preparation [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole and 1- methyl -5- hydroxyl Condensation reaction occurs under alkaline condition for pyrazoles, be finally prepared 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) - 6-(methyl sulphonyl) phenyl] -4,5- dihydro-isoxazole.
It is specifically included in this step:
1. 200mL solvent A is added in 500mL flask, the solvent A in the present embodiment uses DMF, and 14.9g 3- is then added (the bromo- 2- methyl -6- methylsulfonyl phenyl of 3-) -4,5- dihydro isoxazole, 16.18g potassium carbonate, obtains solution B, stirring Under be gradually heated to 140 DEG C.
2. 4.6g 1- methyl -5- hydroxypyrazoles are dissolved by 50mL solvent A, dissolved in the present embodiment using DFM, Then it is all added drop-wise in the solution B of flask, after being added dropwise, at a temperature of continuing after 1. step heats up (at i.e. 140 DEG C) It reacts to complete, obtained solution C.
3. solution C after the reaction was completed, is cooled to room temperature, down in cold water, ethyl acetate extraction, water are then successively carried out It washes, dry concentration to get 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- Dihydro-isoxazole solid.
Above-mentioned 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- dihydro The synthetic route of isoxazole is specifically shown in route 3.The LCMS figure of the synthetic is as shown in Figure 1;The synthetic1HNMR Figure is as shown in Figure 2.
Route 3
Embodiment 2-7 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- two The synthetic method of hydrogen isoxazole
Embodiment 2-7 be respectively a kind of 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) benzene Base] -4,5- dihydro-isoxazole synthetic method, the synthetic method of synthetic method and synthetic route and embodiment 1 is essentially identical, The difference is that each step 2. in solvent for use type and add the variation of each parameter of materials, be specifically shown in Table 1
Table 1
8 3- of embodiment [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- dihydro The application of isoxazole
This implementation is the 3- [2- methyl -3-(1- methyl-1 H- pyrrole using any one synthetic method preparation in embodiment 1-7 Azoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] and -4,5- dihydro-isoxazole application, i.e., prepared 3- [2- methyl -3-(1- Methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] and -4,5- dihydro-isoxazole can be used as standard reference material detection Topramezone is with the presence or absence of 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- How much are dihydro-isoxazole and its content.
Furthermore during synthesizing topramezone in aforementioned manners, it may be used as standard items detection and monitor this impurity Situation is generated, this is significant to the improvement of reaction condition.As shown in Fig. 8 a to Fig. 8 c, by comparing topramezone standard items With the liquid phase figure and 3- of the topramezone in production [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphur Acyl group) phenyl] -4,5- dihydro-isoxazole liquid phase figure, it is known that in the topramezone product of production contain 3- [2- methyl -3-(1- Methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- dihydro-isoxazole impurity, further illustrate 3- [2- Methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- dihydro-isoxazole is as standard items Application value.

Claims (7)

1. a kind of synthetic method of topramezone impurity, it is characterised in that: the impurity is 3- [2- methyl -3-(1- methyl-1 H- Pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- dihydro-isoxazole, synthetic method include successively carry out it is following Step:
1) prepared by raw material, including preparation 3- [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole and 1- Methyl -5- hydroxypyrazoles, the system of [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole wherein the 3- Preparation Method is, with 2,3- dimethylaniline for starting material, by first vulcanization, bromo, oxidation, at oxime, chloro cyclization synthesis 3- [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole;
The synthetic method of the 1- methyl -5- hydroxypyrazoles is to synthesize 1- first with methyl hydrazine reaction with 3- methoxy-methyl acrylate Base -5- hydroxypyrazoles;
2) condensation reaction
By the 3- of preparation [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole and 1- methyl -5- hydroxyl Condensation reaction occurs under alkaline condition for pyrazoles, be finally prepared 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) - 6-(methyl sulphonyl) phenyl] -4,5- dihydro-isoxazole.
2. the synthetic method of topramezone impurity according to claim 1, it is characterised in that:
The 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] the different evil of -4,5- dihydro The synthetic line of azoles are as follows:
3. the synthetic method of topramezone impurity according to claim 1 or 2, it is characterised in that the step 2 is according to such as Lower sequence of steps carries out:
1. catalyst alkali and 3- [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole is added to solvent A Middle dissolution obtains solution B, and solution B is warming up to 80~150 DEG C;
2. being added dropwise in reaction flask after 1- methyl -5- hydroxypyrazoles are dissolved with solvent A, mixed with solution B, and 1. in step At a temperature of fully reacting, after the reaction was completed reaction liquid C;
3. reaction liquid C is down to room temperature and is poured onto ice water, is extracted, be washed with water organic with ethyl acetate or methylene chloride Phase is concentrated later up to 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- bis- Hydrogen isoxazole.
4. the synthetic method of topramezone impurity according to claim 3, it is characterised in that: the step 1. in catalysis Agent alkali is any one in sodium carbonate, potassium carbonate, sodium hydroxide or potassium hydroxide, the dosage and 3- [the bromo- 2- first of 3- of the alkali Base -6-(methyl sulphonyl) phenyl] -4,5- dihydro-isoxazole dosage molar equivalent ratio be 0.5~5:1.
5. the synthetic method of topramezone impurity according to claim 3, it is characterised in that: the step 1. with step 2. Used in solvent A be DMF, DMAC, NMP in any one.
6. the synthetic method of topramezone impurity according to claim 3, it is characterised in that: 1- methyl -5- hydroxyl used The molar equivalent ratio of pyrazoles and 3- [the bromo- 2- methyl -6-(methyl sulphonyl of 3-) phenyl] -4,5- dihydro-isoxazole dosage is 1~ 1.5:1。
7. 3- [2- obtained by a kind of synthetic method of topramezone impurity described in any one of -6 according to claim 1 Methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] and -4,5- dihydro-isoxazole application, it is special Sign is: the 3- [2- methyl -3-(1- methyl-1 H- pyrazoles -5- oxygroup) -6-(methyl sulphonyl) phenyl] -4,5- dihydro is different Oxazole is used as standard items, to detect and monitor the synthesis of topramezone.
CN201910355436.5A 2019-04-29 2019-04-29 The synthetic method and its application of topramezone impurity Pending CN110105349A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910355436.5A CN110105349A (en) 2019-04-29 2019-04-29 The synthetic method and its application of topramezone impurity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910355436.5A CN110105349A (en) 2019-04-29 2019-04-29 The synthetic method and its application of topramezone impurity

Publications (1)

Publication Number Publication Date
CN110105349A true CN110105349A (en) 2019-08-09

Family

ID=67487555

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910355436.5A Pending CN110105349A (en) 2019-04-29 2019-04-29 The synthetic method and its application of topramezone impurity

Country Status (1)

Country Link
CN (1) CN110105349A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111848536A (en) * 2020-07-17 2020-10-30 山东京博生物科技有限公司 Preparation method of 3- [ 3-bromo-2-methyl-6- (methylsulfonyl) phenyl ] -4, 5-dihydroisoxazole
CN112094211A (en) * 2020-09-25 2020-12-18 江苏七洲绿色化工股份有限公司 Preparation method of topramezone intermediate
CN112694425A (en) * 2020-12-29 2021-04-23 利民化学有限责任公司 Method for preparing topramezone intermediate by using supergravity reaction
CN115385832A (en) * 2022-09-13 2022-11-25 江苏七洲绿色科技研究院有限公司 Preparation method of 2, 3-dimethyl 4-methylsulfonyl bromobenzene

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1248255A (en) * 1997-01-17 2000-03-22 巴斯福股份公司 3-heterocyclyl-substituted benzoyl derivatives
WO2003047346A1 (en) * 2001-12-05 2003-06-12 Bayer Cropscience Aktiengesellschaft Herbicides based on substituted carboxylic acid anilides
CN103788083A (en) * 2014-03-10 2014-05-14 中国药科大学 Method for preparing herbicide topramezone
CN104693195A (en) * 2014-12-27 2015-06-10 安徽久易农业股份有限公司 Preparation method of topramezone
CN107325091A (en) * 2017-07-13 2017-11-07 湖南海利化工股份有限公司 A kind of preparation method of benzene pyrazoles humulone
CN108218851A (en) * 2018-03-09 2018-06-29 安徽久易农业股份有限公司 It is a kind of to improve the method for preparing topramezone
CN109320457A (en) * 2018-10-12 2019-02-12 凯莱英医药化学(阜新)技术有限公司 The preparation method and device of hydroxypyrazoles

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1248255A (en) * 1997-01-17 2000-03-22 巴斯福股份公司 3-heterocyclyl-substituted benzoyl derivatives
WO2003047346A1 (en) * 2001-12-05 2003-06-12 Bayer Cropscience Aktiengesellschaft Herbicides based on substituted carboxylic acid anilides
CN103788083A (en) * 2014-03-10 2014-05-14 中国药科大学 Method for preparing herbicide topramezone
CN104693195A (en) * 2014-12-27 2015-06-10 安徽久易农业股份有限公司 Preparation method of topramezone
CN107325091A (en) * 2017-07-13 2017-11-07 湖南海利化工股份有限公司 A kind of preparation method of benzene pyrazoles humulone
CN108218851A (en) * 2018-03-09 2018-06-29 安徽久易农业股份有限公司 It is a kind of to improve the method for preparing topramezone
CN109320457A (en) * 2018-10-12 2019-02-12 凯莱英医药化学(阜新)技术有限公司 The preparation method and device of hydroxypyrazoles

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
V. P. KULINICH ET AL.: "Synthesis and Spectral Properties of the Metallophthalocyanines with the Fragments of Substituted Pyrazoles", 《RUSSIAN JOURNAL OF GENERAL CHEMISTRY》 *
姜宜飞 等: "苯唑草酮原药高效液相色谱分析方法研究", 《农药科学与管理》 *
黄腾: "苯唑草酮重要中间体的合成及工艺研究", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111848536A (en) * 2020-07-17 2020-10-30 山东京博生物科技有限公司 Preparation method of 3- [ 3-bromo-2-methyl-6- (methylsulfonyl) phenyl ] -4, 5-dihydroisoxazole
CN112094211A (en) * 2020-09-25 2020-12-18 江苏七洲绿色化工股份有限公司 Preparation method of topramezone intermediate
CN112094211B (en) * 2020-09-25 2022-04-29 江苏七洲绿色化工股份有限公司 Preparation method of topramezone intermediate
CN112694425A (en) * 2020-12-29 2021-04-23 利民化学有限责任公司 Method for preparing topramezone intermediate by using supergravity reaction
CN112694425B (en) * 2020-12-29 2022-04-26 利民化学有限责任公司 Method for preparing topramezone intermediate by using supergravity reaction
CN115385832A (en) * 2022-09-13 2022-11-25 江苏七洲绿色科技研究院有限公司 Preparation method of 2, 3-dimethyl 4-methylsulfonyl bromobenzene

Similar Documents

Publication Publication Date Title
CN110105349A (en) The synthetic method and its application of topramezone impurity
CN111393427B (en) Synthetic method of sulfuryl pyraflufen
WO2020147861A1 (en) Electrochemical preparation method for β-trifluoromethylamide compound
EP3133061B1 (en) Florfenicol synthesizing method
CN112125898B (en) Preparation method of topramezone
CN107586268A (en) A kind of preparation method of imrecoxib and its intermediate
CN105732444B (en) A kind of his synthetic method of Baily department
JP2005509608A (en) Method for producing benzenesulfonyl compound
CN106699570A (en) Synthesis method for (2-chloro-5-iodophenyl)(4-fluorophenyl)ketone
CN107365296A (en) Preparation method as the pyridine imidazolone derivatives of EV71 and CAV16 viral inhibitors
CN114315748A (en) Synthesis method of flurarana
CN113735791A (en) Synthetic method of 3-bromo-5, 5-dimethyl-4, 5-dihydroisoxazole
CN110294748B (en) Synthesis method of teneligliptin key intermediate
CN110483429B (en) Preparation method of 3, 5-disubstituted-4, 5-dihydroisoxazole
CN108546253A (en) The method that multistep synthesizes 2- benzyl -1,5- dihydrobenzos [e] [1,4] oxygen azatropylidene
CN106866573A (en) A kind of method of the ketone compounds of 1,3,4 oxadiazole 2 such as carbon dioxide synthesis oxadiazon
CN114957233A (en) Sulfoxapyrazole and preparation method thereof
CN114805188B (en) Fluopicolide synthesis method
CN103113315A (en) Preparation method of 1-aryl substituted 1H-1, 2, 3-triazole compound
CN101407496A (en) Method for synthesizing 3,5-disubstituted pyrazole
CN110878043B (en) Synthetic method of intermediate 6-methoxypyridine-3-formaldehyde of antihypertensive drugs of dipine class
Li et al. Palladium-catalyzed aerobic oxyarylthiolation of alkynone O-methyloximes with arylhydrazines and elemental sulfur
Wang et al. Convenient synthesis of 4, 5-unsubstituted 3-aroylisoxazoles from methyl aryl ketones and (vinylsulfonyl) benzene in water
CN115385903A (en) Preparation method of cyano-substituted benzoxazine-4-one derivative
CN109195961A (en) The method for being used to prepare heteroaryl carboxylic acid

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20210917

Address after: 052200 Ma Yu Cun, Jinzhou City, Shijiazhuang City, Hebei Province

Applicant after: HEBEI LANSHENG BIOTECH Co.,Ltd.

Address before: 050000 26 Yuxiang Street, Shijiazhuang City, Hebei Province

Applicant before: HEBEI University OF SCIENCE AND TECHNOLOGY

TA01 Transfer of patent application right
RJ01 Rejection of invention patent application after publication

Application publication date: 20190809

RJ01 Rejection of invention patent application after publication